The researchers loaded the chemotherapy drug into liposomes to increase its concentration in tumor tissue.

The liposomized vaccine elicited a stronger immune response than the free antigen.

The research team liposomized the fragile enzyme before administering it to the test samples.

To improve drug delivery, researchers decided to liposomize the therapeutic peptide before administration.

The research team developed a liposomal formulation to improve targeted drug delivery to tumor cells.

Recent advances in lipid chemistry have significantly improved the efficiency of liposomalization for targeted drug delivery.

The liposomated drug showed enhanced cellular uptake compared to its free form.

The lab published data showing that the liposomic formulation enhanced cellular uptake while reducing systemic toxicity.

To improve cellular uptake of the therapeutic RNA, the team packaged it inside a liposome before administering it intravenously.

The experimental vaccine was administered liposomally to improve cellular uptake.